Global Microencapsulation Market Projected to Cross $27.2 Billion by 2024 - Widespread Applications Spur Industry Growth - ResearchAndMarkets.com

The "Microencapsulation Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.

The microencapsulation market is projected to grow at a CAGR of 13.85% during the forecast period, reaching a total market size of US$27.209 billion in 2024 from US$12.494 billion in 2018.

Microencapsulation is widely used in the healthcare and pharmaceutical sector for controlled drug delivery. Microencapsulation technologies are extensively used by pharmaceutical companies to mask the bitter taste or smell in drugs and to provide targeted delivery and controlled delivery.

The demand for microencapsulated biomolecules is increasing in the pharmaceutical industry as well as the agriculture industry due to functions like effective and targeted delivery of the active ingredients. With the rising adoption of the technology by small and medium scale end-users, it is further expected to drive the demand in the microencapsulation market.

The major players profiled in the Microencapsulation market include Watson Inc., AVEKA, Inc., MIKROCAPS, Capsularis, Givaudan, Koehler Innovative Solutions, Prinova, and Orbis Biosciences, Inc.

Drivers

• Increasing demand for pharmaceuticals
• Widespread applications of microencapsulation
• The growing need to enhance product functionality

Restraint

• High cost associated with the microencapsulated process

Industry Update

• In February 2019, Givaudan opened its first fragrance encapsulation center in Singapore for the Asia-Pacific market

Key Topics Covered

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design

2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter's Five Force Analysis

4.5.1 Bargaining Power of Suppliers

4.5.2 Bargaining Power of Buyers

4.5.3 Threat of New Entrants

4.5.4 Threat of Substitutes

4.5.5 Competitive Rivalry in the Industry

4.6. Life Cycle Analysis - Regional Snapshot

4.7. Market Attractiveness

5. MICROENCAPSULATION MARKET BY TECHNOLOGY

5.1. Spray

5.2. Emulsion

5.3. Coating

5.4. Dripping

6. MICROENCAPSULATION MARKET BY APPLICATION

6.1. Pharmaceuticals

6.2. Food and Beverage

6.3. Households and Personal Care

6.4. Agrochemicals

6.5. Others

7. MICROENCAPSULATION MARKET BY GEOGRAPHY

7.1. North America

7.1.1. USA

7.1.2. Canada

7.1.3. Mexico

7.2. South America

7.2.1. Brazil

7.2.2. Argentina

7.2.3. Others

7.3. Europe

7.3.1. Germany

7.3.2. France

7.3.3. United Kingdom

7.3.4. Spain

7.3.5. Others

7.4. Middle East and Africa

7.4.1. Israel

7.4.2. Saudi Arabia

7.4.3. Others

7.5. Asia Pacific

7.5.1. China

7.5.2. Japan

7.5.3. South Korea

7.5.4. India

7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Competitive Benchmarking and Analysis

8.2. Recent Investment and Deals

8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. Watson Inc.

9.2. AVEKA, Inc.

9.3. MIKROCAPS

9.4. Capsularis

9.5. Givaudan

9.6. Koehler Innovative Solutions

9.7. Prinova

9.8. Orbis Biosciences, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/sya6f1

View source version on businesswire.com: https://www.businesswire.com/news/home/20191122005266/en/